Patents by Inventor Richard Carleton

Richard Carleton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170355940
    Abstract: Vascularizing cell aggregates or tissue segments in a microfluidic device by filling a chamber within the device with a matrix that allows for endothelial sprouting; creating at least three voids within the matrix, of which at least two outer voids are lumenally connected to separate perfusion paths within the device and at least one additional void is positioned in between the at least two outer voids; endothelializing the at least two outer voids; introducing at least one cell type, matrix material, tissue segment, or combinations thereof into the void between the two outer voids; and using vascular growth factors to induce the endothelial cells to sprout into the matrix until the at least three voids are interconnected by endothelial sprouts.
    Type: Application
    Filed: November 19, 2015
    Publication date: December 14, 2017
    Applicant: NORTIS, INC.
    Inventors: Thomas Neumann, Mark E. Fauver, Richard Carleton Hulit
  • Publication number: 20040171632
    Abstract: Mitotic inhibitors such as paclitaxel have improved antitumor activity when used in combination with a selective MEK inhibitor, especially a phenyl amine compound of Formula I and II: 1
    Type: Application
    Filed: November 3, 2003
    Publication date: September 2, 2004
    Inventors: Richard Carleton Gowan, Judith Sebolt-Leopold
  • Patent number: D675502
    Type: Grant
    Filed: October 3, 2011
    Date of Patent: February 5, 2013
    Inventor: Richard Carleton